CD44 and glioma: We also examined the stem cell component through a sphere formation assay (Figure S6A) and CD44/ESA staining (Figure 6B) of TMZ‐treated cells, and the results showed that IFI30 can enhance the stemness and TMZ resistance of glioma, which represents a new direction for future studies and current studies that are ongoing in our laboratory.